⏱ News is delayed by 15 minutes. Sign in for real-time access.
Sign in
ERAS News
Erasca, Inc. Common Stock
Form 8-K
sec.gov
ERAS
Erasca Reports Fourth Quarter and Full Year 2025 Business Updates and Financial Results
globenewswire.com
ERAS
Erasca Reports Fourth Quarter and Full Year 2025 Business Updates and Financial Results
globenewswire.com
ERAS
Erasca Exercises Option to Secure Worldwide Rights for ERAS-0015 Pan-RAS Molecular Glue to Include China, Hong Kong, and Macau
globenewswire.com
ERAS
Erasca Exercises Option to Secure Worldwide Rights for ERAS-0015 Pan-RAS Molecular Glue to Include China, Hong Kong, and Macau
globenewswire.com
ERAS
Erasca and Tango Therapeutics Enter into Clinical Collaboration to Evaluate Combination of ERAS-0015 and Vopimetostat
globenewswire.com
TNGX
ERAS
Erasca and Tango Therapeutics Enter into Clinical Collaboration to Evaluate Combination of ERAS-0015 and Vopimetostat
globenewswire.com
ERAS
TNGX
Erasca Announces Issuance of a U.S. Patent Covering Pan-KRAS Inhibitor ERAS-4001
globenewswire.com
ERAS
Registration Momentum Builds Across the Oncology Pipeline
globenewswire.com
ACRV
KPTI
ERAS
ONCY
INCY
Erasca to Present at Upcoming Conferences in February
globenewswire.com
ERAS